Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Christianson, Sara ^a   Voth, Dylan ^b   Wolfe, Joyce ^a   Sharma, Meenu K ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CRITICAL CONCENTRATION; EMBB GENE; GENE MUTATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84907916613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108911     Document Type: Article

References (12)

1. Clinical and Laboratory Standards Institute (2011) Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes: Approved standard - second edition. CLSI document M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
2. Bemer P, Palicova F, Rusch-Gerdes S, Drugeon HB, Pfyffer GE (2002) Multicenter evaluation of fully automated BACTEC mycobacteria growth indicator tube 960 system for susceptibility testing of mycobacterium tuberculosis. J Clin Microbiol 40: 150-154.
3. Kruuner A, Yates MD, Drobniewski FA (2006) Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of mycobacterium tuberculosis. J Clin Microbiol 44: 811-818.
4. Sirgel FA, Warren RM, Streicher EM, Victor TC, van Helden PD, et al. (2012) embB306 mutations as molecular indicators to predict ethambutol susceptibility in mycobacterium tuberculosis. Chemotherapy 58: 358-363. 10.1159/000343474; 10.1159/000343474.
5. Gumbo T (2010) New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability. Antimicrob Agents Chemother 54: 1484-1491. 10.1128/AAC.01474-09; 10.1128/AAC.01474-09.
6. Safi H, Lingaraju S, Amin A, Kim S, Jones M, et al. (2013) Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-beta-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45: 1190-1197. 10.1038/ng.2743; 10.1038/ng.2743.
7. Banu S, Rahman SM, Khan MS, Ferdous SS, Ahmed S, et al. (2013) Discordance across several drug susceptibility methods for drug-resistant tuberculosis in a single laboratory. J Clin Microbiol. 10.1128/JCM.02378-13.
8. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, et al. (1997) The emb operon, a gene cluster of mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3: 567-570.
9. Safi H, Fleischmann RD, Peterson SN, Jones MB, Jarrahi B, et al. (2010) Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in mycobacterium tuberculosis. Antimicrob Agents Chemother 54: 103-108. 10.1128/AAC.01288-09; 10.1128/AAC.01288-09.
10. Safi H, Sayers B, Hazbon MH, Alland D (2008) Transfer of embB codon 306 mutations into clinical mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 52: 2027-2034. 10.1128/AAC.01486-07; 10.1128/AAC.01486-07.
11. Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, et al. (2000) Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of mycobacterium tuberculosis. Antimicrob Agents Chemother 44: 326-336.
12. Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker K, et al. (2010) embCAB sequence variation among ethambutol-resistant mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 65: 1359-1367. 10.1093/jac/dkq120; 10.1093/jac/dkq120.